Start free trial

Latest Oncopeptides News & Updates

See the latest news and media coverage for Oncopeptides. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Oncopeptides

Biotech developing therapies for difficult-to-treat cancers

oncopeptides.com
Headquarters
Stockholm, Sweden
Founded year
2000
Company type
Public company
Number of employees
81–200
Industry
Pharmaceuticals

Last updated

Latest news about Oncopeptides

In short: Oncopeptides planned SEK 100 million share issue, received positive CHMP opinion and reported glioblastoma data.

Company announcements

Oncopeptides

Oncopeptides receives CHMP positive opinion for Pepaxti label expansion, advancing approval for third-line treatment. 🚀

The Committee for Medicinal Products for Human Use recommends expanding the indication for Pepaxti to third-line treatment, a critical step toward regulatory approval and market access.

Unlock all announcements with a

Media coverage

Dagens industri

The discount in Oncopeptides was this large

Oncopeptides, a biotech company focused on hard-to-treat cancers, announced that the subscription price has been set at 2 kronor per share in...

Dagens industri

Oncopeptides surges after study data

Biotech company Oncopeptides surges double-digit after the company presented data from the first patients in an ongoing study. "A major breakthrough...

Dagens industri

European breakthrough for Oncopeptides cancer drug

The European Medicines Agency's advisory committee (CHMP) recommends approval of biotechnology company Oncopeptides' expansion of the...

Unlock all articles with a

Never miss news about Oncopeptides

Track Oncopeptides and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Oncopeptides competitors & trending companies

Browse news for competitors to Oncopeptides and other trending companies.